The Glaucoma Foundation invites you to join us for our biennial Glaucoma Symposium, an accredited CE/CME seminar focused on advancing glaucoma care.
This year, the meeting will be held on Saturday, May 30th at the NYC Bar Association, 42 West 44th Street, NYC.
7:15 AM – Continental Breakfast
7:50 AM – Welcome by TGF Chairman Gregory Harmon, MD & President /CEO Elena Sturman
PROGRAM
Session 1 – 8:00 am to 10:00 am
Surgical Innovations in Glaucoma
Gus De Moraes, Moderator
This course will provide an in-depth exploration of the latest advances in glaucoma surgery. Recent developments in minimally invasive glaucoma surgery (MIGS) will be discussed along with the expanding range of implant designs, their mechanisms of action, and surgical indications. This course will also explore best practices for co-managing glaucoma surgical patients, from pre-operative assessment to long-term post-operative care. How ophthalmologists and optometrists can work together to select appropriate candidates, optimize pre-surgical management, and monitor outcomes after traditional, MIGS, and other glaucoma procedures will be discussed.
FACULTY
Arsham Sheybani, MD & Mitch Ibach, OD, FAAO – Trabecular outflow options
Arsham Sheybani, MD – New MIGS developments – When do we go with stand-alone?
Poonam Misra, MD – New surgical developments
Poonam Misra, MD and Mitch Ibach, OD, FAAO- How do we comanage MIGS?
Break
Session 2 – 10:30 AM to 12:30 AM
What’s new in glaucoma diagnosis?
Alon Harris, Moderator
This course examines the concept of personalized glaucoma care with the introduction of genetic testing and the use of artificial intelligence to better understand which individuals may be at increased risk of developing glaucoma or getting worse. This course will also explore how home-based intraocular pressure (IOP) monitoring technologies are reshaping glaucoma detection and management. Available and emerging devices, their accuracy, and clinical applications for capturing IOP fluctuations outside the clinic will be reviewed. Finally, the complex relationship between myopia and glaucoma will be discussed, with an emphasis on diagnostic challenges and management strategies. Participants will explore how myopic structural changes may mimic glaucomatous damage, and how axial length and optic disc morphology influence risk assessment. Current evidence on the increased glaucoma risk in myopic patients will be reviewed, with approaches to differentiate true disease from myopia-related artifacts discussed.
FACULTY
Michael Chaglasian, OD – Remote tonometry and its impact on glaucoma diagnosis and management
C. Gustavo De Moraes, MD, PhD, MPH – Is it glaucoma, or myopia, or both?
Louis R. Pasquale, MD, FARVO – Has personalized medical care for glaucoma arrived?
Lunch
Session 3 – 1:30 PM-3:30 PM
What’s new in glaucoma therapy?
Louis R. Pasquale, MD, FARVO, Moderator
This course explores the current state of neuroprotection research and its potential to transform disease management beyond intraocular pressure control. The scientific rationale for neuroprotection, key clinical trial findings, and emerging therapeutic targets aimed at preserving retinal ganglion cells and optic nerve function will be discussed. Glaucoma clinical trials will be discussed and how they influence our care. Also, the evolution of glaucoma therapy will be discussed including the role laser and medical therapy plays. New information on laser technology for glaucoma therapy will be described as well as the current role for medical and non-medical therapeutic devices. And finally, how the future of glaucoma care is evolving and how recent innovations may improve how we take care of people.
FACULTY
Thomas V. Johnson, MD, PhD – How close are we to neuroprotection?
Tony Realini, MD – Evidence-based glaucoma care: Lessons from clinical trials
Alex A. Huang, MD, PhD – New advances in non-medical and medical therapy for glaucoma
Robert N. Weinreb, MD – The future of glaucoma diagnosis and management